NE HEALTH BUREAU NEW DELHI, NOV 29 The Drugs Controller General of India (DCGI) and the institutional ethics committee at the implementation site are investigating if the adverse event as claimed to have been suffered by a COVID-19 vaccine trial participant in Chennai are related to the shot administered to him. A 40-year-old Chennai-based business … Continue reading DCGI and institutional ethics committee investigating claim of adverse event in COVID vaccine trial, says Officials